Want to see DE:MED full AI Analyst Report?

MEDICLIN (MED) Price & Analysis

1 Followers

MED Stock Chart & Stats

€4.26

-€0.10(-2.35%)

At close: Jul 27 4:00 PM EDT

€4.26

-€0.10(-2.35%)

Day’s Range― - ―

52-Week Range€2.86 - €4.26

Previous CloseN/A

Volume15.80K

Average Volume (3M)5.25K

Market Cap

€197.60M

Enterprise Value€483.17M

Total Cash (Recent Filing)€152.40M

Total Debt (Recent Filing)€384.07M

Price to Earnings (P/E)6.9

Beta0.24

Next Earnings

Jul 30, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.97%

Share Statistics

EPS (TTM)0.60

Shares Outstanding47,500,000

10 Day Avg. Volume4,347

30 Day Avg. Volume5,253

Financial Highlights & Ratios

PEG Ratio1.78

Price to Book (P/B)0.71

Price to Sales (P/S)0.22

P/FCF Ratio3.42

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.78

Revenue Forecast (FY)€805.60M

Bulls Say, Bears Say

Bulls Say

Cash GenerationConsistent positive operating cash flow (~€94m TTM) and meaningful free cash flow (~€49m TTM) provide durable internal funding for maintenance capex, working capital and strategic investments. This cash profile supports ongoing operations and gradual deleveraging without reliance on equity issuance.

Revenue Growth And Improving Operating PerformanceA 26% TTM revenue increase with positive EBIT and net margins signals sustained demand and improving utilization across facilities. Persistent top-line growth enlarges the earnings base, helps absorb fixed costs, and creates structural room to sustain margins if operational execution remains consistent.

Diversified Care-segment FootprintA multi-segment network spanning hospitals, rehabilitation and long-term nursing creates diversified, recurring revenue streams tied to different payers and care cycles. This structural diversification reduces single-segment exposure, enables cross-referral synergies and stabilizes utilization over economic cycles.

Bears Say

Elevated LeverageA debt-to-equity ratio around 1.46x, while improved from prior years, leaves the capital structure leveraged relative to peers. Elevated leverage reduces financial flexibility, increases interest-cost sensitivity, and constrains the speed at which the company can invest, pursue M&A, or absorb reimbursement shocks.

Margin Volatility And Prior LossHistoric swings in profitability, including a full-year loss in 2023, indicate inconsistent cost control or revenue mix shifts. Persistent margin volatility undermines forecasting, makes capital allocation riskier, and raises the chance that short-term reimbursement or staffing pressures reassert and compress earnings.

Weak FCF Conversion & Negative FCF GrowthFree cash flow equating to roughly half of net income and negative FCF growth in the TTM reduces the company's ability to accelerate debt paydown or increase investment. Weaker cash conversion limits resilience to shocks and means leverage reduction may be gradual even if earnings improve.

MED FAQ

What was MEDICLIN AG’s price range in the past 12 months?

MEDICLIN AG lowest stock price was €2.86 and its highest was €4.26 in the past 12 months.

What is MEDICLIN AG’s market cap?

MEDICLIN AG’s market cap is €197.60M.

When is MEDICLIN AG’s upcoming earnings report date?

MEDICLIN AG’s upcoming earnings report date is Jul 30, 2026 which is today.

How were MEDICLIN AG’s earnings last quarter?

MEDICLIN AG released its earnings results on May 04, 2026. The company reported €0.074 earnings per share for the quarter, beating the consensus estimate of N/A by €0.074.

Is MEDICLIN AG overvalued?

According to Wall Street analysts MEDICLIN AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MEDICLIN AG pay dividends?

MEDICLIN AG pays a Annually dividend of €0.04 which represents an annual dividend yield of 0.97%. See more information on MEDICLIN AG dividends here

What is MEDICLIN AG’s EPS estimate?

MEDICLIN AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MEDICLIN AG have?

MEDICLIN AG has 47,500,000 shares outstanding.

What happened to MEDICLIN AG’s price movement after its last earnings report?

MEDICLIN AG reported an EPS of €0.074 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.725%.

Which hedge fund is a major shareholder of MEDICLIN AG?

Currently, no hedge funds are holding shares in DE:MED

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MEDICLIN Stock Smart Score

Outperform

Technicals

Fundamentals

Return on Equity

0.97%

Trailing 12-Months

Asset Growth

-6.83%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

MEDICLIN AG

Mediclin AG is a German healthcare enterprise primarily engaged in managing hospitals across the nation. Its operations are categorized into three main segments: Post-Acute, Acute, and various other related activities. The company offers a comprehensive range of medical specializations, encompassing fields such as neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, and surgical interventions, in addition to general nursing care. Furthermore, Mediclin provides specialized services like ear, nose, and throat (ENT) treatment and acute outpatient care. As of December 31, 2021, its extensive network comprised 34 clinics, 7 nursing care facilities, and 11 medical care centres. This infrastructure collectively provided a significant capacity of 7,831 beds and 482 nursing places, distributed across eleven of Germany's federal states. The company's corporate headquarters are situated in Offenburg, Germany.